Episurf Medical AB (publ) (EPIS-B) — Strategic Asset Allocation Index
Episurf Medical AB (publ) (EPIS-B) has a Strategic Asset Allocation Index of 10.7% as of December 2025. Strategic assets (PP&E of Skr5.10 Million plus long-term investments of Skr-) total Skr5.10 Million, measured against net assets of Skr47.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Episurf Medical AB (publ) liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Episurf Medical AB (publ) Strategic Asset Allocation Index (2013–2025)
This chart shows how Episurf Medical AB (publ)'s Strategic Asset Allocation Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 10.7%, representing strategic assets of Skr5.10 Million against net assets of Skr47.50 Million SEK. See Episurf Medical AB (publ) (EPIS-B) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Episurf Medical AB (publ) (2013–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Episurf Medical AB (publ) from 2013 to 2025, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see EPIS-B market cap.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.7% | Skr5.10 Million | Skr5.10 Million | Skr- | Skr47.50 Million | ▲ +7.4 pp |
| 2024 | 3.3% | Skr2.80 Million | Skr2.80 Million | Skr- | Skr83.80 Million | ▼ -3.3 pp |
| 2023 | 6.6% | Skr5.60 Million | Skr5.60 Million | Skr- | Skr84.50 Million | ▲ +2.9 pp |
| 2022 | 3.8% | Skr6.70 Million | Skr6.70 Million | Skr- | Skr177.70 Million | ▲ +2.5 pp |
| 2021 | 1.3% | Skr3.30 Million | Skr3.30 Million | Skr- | Skr252.80 Million | ▼ -0.9 pp |
| 2020 | 2.2% | Skr3.80 Million | Skr3.80 Million | Skr- | Skr169.50 Million | ▼ -12.3 pp |
| 2019 | 14.5% | Skr6.00 Million | Skr6.00 Million | Skr- | Skr41.40 Million | ▲ +14.3 pp |
| 2018 | 0.2% | Skr100.00K | Skr100.00K | Skr- | Skr44.80 Million | ▼ 0.0 pp |
| 2017 | 0.2% | Skr200.00K | Skr200.00K | Skr- | Skr85.57 Million | ▼ -0.6 pp |
| 2016 | 0.8% | Skr382.05K | Skr382.05K | Skr- | Skr48.70 Million | ▲ +0.4 pp |
| 2015 | 0.4% | Skr423.84K | Skr423.84K | Skr- | Skr109.93 Million | ▼ -0.7 pp |
| 2014 | 1.1% | Skr426.68K | Skr426.68K | Skr- | Skr38.85 Million | ▲ +0.4 pp |
| 2013 | 0.7% | Skr519.20K | Skr519.20K | Skr- | Skr71.61 Million | — |